JAAD Case Reports (Feb 2022)
Serum autoantibodies against the extracellular region of α6β4 integrin in a patient with dipeptidyl peptidase-4 inhibitor–induced bullous pemphigoid
- Chigusa Yamashita, MD,
- Noriko Arase, MD, PhD,
- Shuhei Higuchi, MS,
- Hisashi Arase, MD, PhD,
- Junichi Takagi, PhD,
- Satoshi Nojima, MD, PhD,
- Atsushi Tanemura, MD, PhD,
- Manabu Fujimoto, MD, PhD
Affiliations
- Chigusa Yamashita, MD
- Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan
- Noriko Arase, MD, PhD
- Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan; Correspondence and reprint requests to: Noriko Arase, MD, PhD, Department of Dermatology, Integrated Medicine, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
- Shuhei Higuchi, MS
- Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
- Hisashi Arase, MD, PhD
- Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan
- Junichi Takagi, PhD
- Laboratory for Protein Synthesis and Expression, Institute of Protein Research, Osaka University, Osaka, Japan
- Satoshi Nojima, MD, PhD
- Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan
- Atsushi Tanemura, MD, PhD
- Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan
- Manabu Fujimoto, MD, PhD
- Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan; Laboratory of Cutaneous Immunology, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan
- Journal volume & issue
-
Vol. 20
pp. 65 – 68